Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2017 (2017), Article ID 6504960, 10 pages
https://doi.org/10.1155/2017/6504960
Research Article

Tumor Budding, uPA, and PAI-1 in Colorectal Cancer: Update of a Prospective Study

1Institute of Pathology, Klinikum Augsburg, Augsburg, Germany
2Institute of Laboratory Medicine and Microbiology, Klinikum Augsburg, Augsburg, Germany
3Clinical and Population-Based Cancer Registry Augsburg, Augsburg, Germany
4Department of Visceral Surgery, Klinikum Augsburg, Augsburg, Germany

Correspondence should be addressed to Bruno Märkl; ed.grubsgua-mukinilk@lkream.onurb

Received 5 September 2016; Revised 18 December 2016; Accepted 5 January 2017; Published 12 February 2017

Academic Editor: Mitsuro Kanda

Copyright © 2017 Bruno Märkl et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Hanahan and R. A. Weinberg, “Hallmarks of cancer: the next generation,” Cell, vol. 144, no. 5, pp. 646–674, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. W. H. Fridman, F. Pagès, C. Sautes-Fridman, and J. Galon, “The immune contexture in human tumours: impact on clinical outcome,” Nature Reviews Cancer, vol. 12, no. 4, pp. 298–306, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. American-Cancer-Society, Cancer Facts & Figures 2016, American Cancer Society, Atlanta, Ga, USA, 2016.
  4. B. Märkl, I. Renk, D. V. Oruzio et al., “Tumour budding, uPA and PAI-1 are associated with aggressive behaviour in colon cancer,” Journal of Surgical Oncology, vol. 102, no. 3, pp. 235–241, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. J. R. Jass, Y. Ajioka, J. P. Allen et al., “Assessment of invasive growth pattern and lymphotic infiltration in colorectal cancer,” Histopathology, vol. 28, no. 6, pp. 543–548, 1996. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Mutoh, N. Niho, M. Komiya et al., “Plasminogen activator inhibitor-1 (Pai-1) blockers suppress intestinal polyp formation in Min mice,” Carcinogenesis, vol. 29, no. 4, pp. 824–829, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. P. Minoo, K. Baker, D. Baumhoer, L. Terracciano, A. Lugli, and I. Zlobec, “Urokinase-type plasminogen activator is a marker of aggressive phenotype and an independent prognostic factor in mismatch repair-proficient colorectal cancer,” Human Pathology, vol. 41, no. 1, pp. 70–78, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. Yamada, T. Arao, K. Matsumoto et al., “Plasma concentrations of VCAM-1 and PAI-1: a predictive biomarker for post-operative recurrence in colorectal cancer,” Cancer Science, vol. 101, no. 8, pp. 1886–1890, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. N. E. Kushlinskii, E. S. Gershtein, E. A. Korotkova, and V. V. Prorokov, “Prognostic role of tumor-associated proteases in colorectal cancer,” Bulletin of Experimental Biology and Medicine, vol. 154, no. 3, pp. 365–369, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. N. M. Hogan, M. R. Joyce, J. M. Murphy et al., “Impact of Mesenchymal Stem Cell secreted PAI-1 on colon cancer cell migration and proliferation,” Biochemical and Biophysical Research Communications, vol. 435, no. 4, pp. 574–579, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. E. R. Kim, M. H. Yang, Y. J. Lim et al., “Association between plasma levels of plasminogen activator inhibitor-1 and colorectal neoplasms,” Gut and Liver, vol. 7, no. 5, pp. 519–523, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. L. Iacoviello, C. Agnoli, A. De Curtis et al., “Type 1 plasminogen activator inhibitor as a common risk factor for cancer and ischaemic vascular disease: The EPICOR Study,” BMJ Open, vol. 3, no. 11, article 12, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. E. Sánchez-Tilló, O. De Barrios, L. Siles et al., “ZEB1 promotes invasiveness of colorectal carcinoma cells through the opposing regulation of uPA and PAI-1,” Clinical Cancer Research, vol. 19, no. 5, pp. 1071–1082, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Chen, H. Peng, W. Liu et al., “Silencing of plasminogen activator inhibitor-1 suppresses colorectal cancer progression and liver metastasis,” Surgery, vol. 158, no. 6, pp. 1704–1713, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. H. Ueno, J. Murphy, J. R. Jass, H. Mochizuki, and I. C. Talbot, “Tumour ‘budding’ as an index to estimate the potential of aggressiveness in rectal cancer,” Histopathology, vol. 40, no. 2, pp. 127–132, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. F. Prall, “Tumour budding in colorectal carcinoma,” Histopathology, vol. 50, no. 1, pp. 151–162, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. F. Prall, V. Weirich, and C. Ostwald, “Phenotypes of invasion in sporadic colorectal carcinomas related to aberrations of the adenomatous polyposis coli (APC) gene,” Histopathology, vol. 50, no. 3, pp. 318–330, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. J. R. Jass, M. Barker, L. Fraser et al., “APC mutation and tumour budding in colorectal cancer,” Journal of Clinical Pathology, vol. 56, no. 1, pp. 69–73, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. J. García-Solano, P. Conesa-Zamora, J. Trujillo-Santos, D. Torres-Moreno, M. J. Mäkinen, and M. Pérez-Guillermo, “Immunohistochemical expression profile of β-catenin, E-cadherin, P-cadherin, laminin-5γ2 chain, and SMAD4 in colorectal serrated adenocarcinoma,” Human Pathology, vol. 43, no. 7, pp. 1094–1102, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Brabletz, F. Hlubek, S. Spaderna et al., “Invasion and metastasis in colorectal cancer: epithelial-mesenchymal transition, mesenchymal-epithelial transition, stem cells and β-catenin,” Cells Tissues Organs, vol. 179, no. 1-2, pp. 56–65, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. H. J. Nielsen, I. J. Christensen, S. Sorensen, F. Moesgaard, and N. Brunner, “Preoperative plasma plasminogen activator inhibitor type-1 and serum C-reactive protein levels in patients with colorectal cancer. The RANX05 Colorectal Cancer Study Group,” Annals of Surgical Oncology, vol. 7, no. 8, pp. 617–623, 2000. View at Google Scholar
  22. E. Hiendlmeyer, S. Regus, S. Wassermann et al., “β-catenin up-regulates the expression of the urokinase plasminogen activator in human colorectal tumors,” Cancer Research, vol. 64, no. 4, pp. 1209–1214, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Wang, Q. Cao, X. Wang et al., “PAI-1 4G/5G polymorphism contributes to cancer susceptibility: evidence from meta-analysis,” PLoS ONE, vol. 8, no. 2, Article ID e56797, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Fujii, T. Obara, S. Tanno, H. Ura, and Y. Kohgo, “Urokinase-type plasminogen activator and plasminogen activator inhibitor-1 as a prognostic factor in human colorectal carcinomas,” Hepato-Gastroenterology, vol. 46, no. 28, pp. 2299–2308, 1999. View at Google Scholar · View at Scopus
  25. S. Ganesh, C. F. M. Sier, G. Griffioen et al., “Prognostic relevance of plasminogen activators and their inhibitors in colorectal cancer,” Cancer Research, vol. 54, no. 15, pp. 4065–4071, 1994. View at Google Scholar · View at Scopus
  26. H. E. Mulcahy, D. P. O'Donoghue, M. J. Duffy et al., “Urokinase-type plasminogen activator and outcome in Dukes' B colorectal cancer,” The Lancet, vol. 344, no. 8922, pp. 583–584, 1994. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Sato, G. Nishimura, Y. Yonemura et al., “Association of immunohistochemical detection of urokinase-type plasminogen activator with metastasis and prognosis in colorectal cancer,” Oncology, vol. 52, no. 4, pp. 347–352, 1995. View at Publisher · View at Google Scholar · View at Scopus
  28. D.-Q. Seetoo, P. J. Crowe, P. J. Russell, and J.-L. Yang, “Quantitative expression of protein markers of plasminogen activation system in prognosis of colorectal cancer,” Journal of Surgical Oncology, vol. 82, no. 3, pp. 184–193, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. J.-L. Yang, D.-Q. Seetoo, Y. Wang et al., “Urokinase-type plasminogen activator and its receptor in colorectal cancer: independent prognostic factors of metastasis and cancer-specific survival and potential therapeutic targets,” International Journal of Cancer, vol. 89, no. 5, pp. 431–439, 2000. View at Publisher · View at Google Scholar · View at Scopus
  30. L. Herszènyi, M. Plebani, P. Carraro et al., “The role of cysteine and serine proteases in colorectal carcinoma,” Cancer, vol. 86, no. 7, pp. 1135–1142, 1999. View at Publisher · View at Google Scholar · View at Scopus
  31. V. H. Koelzer, I. Zlobec, and A. Lugli, “Tumor budding in colorectal cancer—ready for diagnostic practice?” Human Pathology, vol. 47, no. 1, pp. 4–19, 2016. View at Publisher · View at Google Scholar · View at Scopus
  32. B. Märkl and H. M. Arnholdt, “Prognostic significance of tumor budding in gastrointestinal tumors,” Expert Review of Anticancer Therapy, vol. 11, no. 10, pp. 1521–1533, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. G. Puppa, C. Senore, K. Sheahan et al., “Diagnostic reproducibility of tumour budding in colorectal cancer: a multicentre, multinational study using virtual microscopy,” Histopathology, vol. 61, no. 4, pp. 562–575, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. C. Beaton, C. P. Twine, G. L. Williams, and A. G. Radcliffe, “Systematic review and meta-analysis of histopathological factors influencing the risk of lymph node metastasis in early colorectal cancer,” Colorectal Disease, vol. 15, no. 7, pp. 788–797, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. H. Ueno, K. Hase, Y. Hashiguchi et al., “Novel risk factors for lymph node metastasis in early invasive colorectal cancer: a multi-institution pathology review,” Journal of Gastroenterology, vol. 49, no. 9, pp. 1314–1323, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Bosch, S. Teerenstra, J. W. De Wilt, C. Cunningham, and I. Nagtegaal, “Predicting lymph node metastasis in pT1 colorectal cancer: a systematic review of risk factors providing rationale for therapy decisions,” Endoscopy, vol. 45, no. 10, pp. 827–834, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. J. R. Jass, M. J. O'Brien, R. H. Riddell, and D. C. Snover, “Recommendations for the reporting of surgically resected specimens of colorectal carcinoma,” Virchows Archiv, vol. 450, no. 1, pp. 1–13, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Vieth, P. Quirke, R. Lambert, L. von Karsa, and M. Risio, “International Agency for Research on C. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition—annotations of colorectal lesions,” Endoscopy, vol. 44, supplement 3, pp. SE131–SE139, 2012. View at Google Scholar
  39. T. Watanabe, M. Itabashi, Y. Shimada et al., “Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer,” International Journal of Clinical Oncology, vol. 17, no. 1, pp. 1–29, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. C. J. H. Van De Velde, P. G. Boelens, J. M. Borras et al., “EURECCA colorectal: multidisciplinary management: European consensus conference colon & rectum,” European Journal of Cancer, vol. 50, no. 1, pp. e1–e34, 2014. View at Publisher · View at Google Scholar · View at Scopus
  41. V. R. Placencio, A. Ichimura, T. Miyata, and Y. A. DeClerck, “Small molecule inhibitors of plasminogen activator inhibitor-1 elicit anti-Tumorigenic and anti-Angiogenic activity,” PLoS ONE, vol. 10, no. 7, Article ID e0133786, 2015. View at Publisher · View at Google Scholar · View at Scopus